Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application.
Ontology highlight
ABSTRACT: Tumors have evolved in various mechanisms to evade the immune system, hindering the antitumor immune response and facilitating tumor progression. Immunotherapy has become a potential treatment strategy specific to different cancer types by utilizing multifarious molecular mechanisms to enhance the immune response against tumors. Among these mechanisms, the ubiquitin-proteasome system (UPS) is a significant non-lysosomal pathway specific to protein degradation, regulated by deubiquitinating enzymes (DUBs) that counterbalance ubiquitin signaling. Ubiquitin-specific proteases (USPs), the largest DUB family with the strongest variety, play critical roles in modulating immune cell function, regulating immune response, and participating in antigen processing and presentation during tumor progres
SUBMITTER: Gao H
PROVIDER: S-EPMC10472646 | biostudies-literature | 2023 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA